@guac · a month ago

Excision's CRISPR gene editing therapy for HIV is heading into human testing after FDA clearance


Annalee Armstrong


A CRISPR-Cas9 gene editing technology that has shown promise in clearing HIV from mice is headed into human testing. Excision BioTherapeutics will usher the CRISPR-based therapy EBT-101 into clinical trials after the FDA cleared an investigational new drug application.